3M, CareFirst BlueCross BlueShield, Lafayette General Health, OSF Healthcare and ProMedica all invested as the healthcare technology provider closed an $11.1m round.

Sanofi is in line for an exit as Revolution Medicines files for a $100m initial public offering on the Nasdaq Global Market.

University Hospital Tübingen's liver disease treatment spinout HepaRegenix has raised $21.6m in all following a series B round that featured Novo and Boehringer Ingelheim.

MassMutual Ventures has followed up on the $50m Southeast Asian fund it launched in late 2018 with a second vehicle dedicated to the region.

The Tasly and Genexine-backed drug developer floated above the mid-point of its range, in an initial public offering that could end up topping $119m.

SymphonyAI Group has taken part in a $150m round for one of its spinoffs, precision cancer therapy developer Concerto HealthAI.

Naver has backed four health and education technology developers – Huray Positive, Ichrogene, N.Cer and SoundGym – through its D2 Startup Factory accelerator.

Foxconn, SK Telecom and Fujifilm have all returned for a round that increased X-ray diagnosis platform developer Nano-X Imaging's overall funding to $55m.

Evive has acquired the medical-treatment comparison platform, which had raised $16.3m in equity and debt financing from investors including Merck GHI.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.